20mg Afanat Afatinib Tablets
Afanar 20mg Tablets contain Afatinib, a tyrosine kinase inhibitor used for treating EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking the activity of ...
20mg Afanat Afatinib Tablets
Afanar 20mg Tablets contain Afatinib, a tyrosine kinase inhibitor used for treating EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking the activity of proteins involved in the growth and spread of cancer cells. Afanar is typically prescribed as a first-line oral therapy in patients whose tumors exhibit specific genetic mutations. It helps slow tumor progression, improve survival rates, and reduce symptoms such as cough and breathing difficulty. Treatment with Afanar should be supervised by an oncologist, with regular monitoring for side effects like diarrhea, rash, and liver function changes.
| Strength | 20 mg |
| Brand Name | AFANAT |
| Form | Tablet |
| Packaging Size | 28 tablets |
| Packaging Type | Box |
| Treatment | Lung Cancer |
